abstract |
The present invention relates to new dibenzothiazepine modulators of D1 receptors, D2 receptors, alpha- 1 adrenergic receptors, alpha-2 adrenergic receptors, H1eceptors, 5-HT1A receptors, and/or 5-HT2 receptors, pharmaceutical compositions thereof, and methods of use thereof. |